Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies. Find out more about cookies.

Click here to dismiss this banner


...see all

Global Anaesthesia Drugs Market Set To Grow To $10.5bn By 2022

LONDON, UK. February 2018:  Visiongain’ has launched a new pharma report Global Anaesthesia Drugs Market 2018-2028: Local Anaesthesia, General Anaesthesia, Inhalation Anaesthesia, Intravenous Anaesthesia, Topical Anaesthesia

This anaesthesia drugs market can be broadly segmented into type and routes of administration. The market is segregated further by type as local anaesthesia and general anaesthesia. Inhalation intravenous and topical are the main forms of routes of administration. The market has also been geographically segmented into North America (US, Canada), Europe (Germany, France, UK, Italy, Spain, Rest of Europe), Asia-Pacific (India, China, Japan, Rest of Asia-Pacific), Rest of World (Brazil, Mexico, Russia, South Africa).

The lead analyst of the report commented The global anaesthesia drugs market is projected to grow at lucrative rate during the forecast period owing to a rising number of surgical procedures globally, developing healthcare infrastructure in emerging economies, and growing number of geriatric population. The escalating prevalence of cancer, stroke, arthritis, and neurological diseases leads to a rising number of surgical procedures. In addition, rising number of road accidents and trauma cases will further drive the growth of the market.”

Leading companies featured in the report include Baxter International, Inc., AbbVie, PAION AG, Pfizer, Hameln Pharmaceuticals, AstraZeneca, Fresenius Kabi, Maruishi Pharmaceuticals, Pacira Pharmaceuticals, Inc


Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

read more

You have successfully subscribed. Thank you.

An internal error has occurred. Please try again later.